CHRISTOPHER PATUSKY - 17 May 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 17 May 2022
Net transactions value: -$254,180
Form type: 4
Filing time: 18 May 2022, 16:30:50 UTC
Previous filing: 08 Apr 2022
Next filing: 08 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$127,800	+2,000	+119%	$63.90	3,680	17 May 2022	Direct	F1
transaction	UTHR	Common Stock	Disposed to Issuer	$381,980	-2,000	-54%	$190.99	1,680	17 May 2022	Direct	F1
holding	UTHR	Common Stock						1,200	17 May 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Share Tracking Award	Options Exercise	$0	-2,000	-57%	$0.000000	1,500	17 May 2022	Common Stock	2,000	$63.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.